Developing an understanding of the relationship of the microbiome to cancer treatment is essential to restoring wellness in complex clinical presentations. Building this knowledge dramatically increases clinical outcomes in cancer.
Find out all you need to know about how the microbiome interact with host immune cells and why this is important.
The consequences of impaired microbiome can increase the risk of degenerative health conditions passing this genetic programming onto future generations.
We urgently need to develop clinical understanding reduce the long-term impact of cancer and this growing health crisis.
Join Professor Luis Vitetta, director of medical research – Medlab clinical Ltd and the University of Sydney, Faculty of Medicine and Health in this on-demand webinar which will cover:
- Understanding The Human Microbiome Project and Bacteria
- How bacteria interact with host immune cells and why is this important
- Immunity presents a protective network of cells for survival
- How the intestinal microbiome is a partner in cancer therapy
acnem Members receive monthly webinars for FREE! Join acnem today!
Professor Luis Vitetta
Currently, Professor Luis Vitetta is Director of Medical Research at Medlab Clinical and Professor with the University of Sydney, Faculty of Medicine and in Sydney. Between the years 2007–2013 he was the Director and Professor of the Centre for Integrative Clinical and Molecular Medicine at the University of Queensland, Faculty…View More